This study is testing if giving blood transfusions at home is practical and acceptable for people with blood cancers (hematologic malignancy), bone marrow problems (myelodysplastic syndromes), or acute myeloid leukemia who need regular transfusions. You would receive red blood cells and platelets at home. The study wants to see if this home transfusion program works well and if patients like it. It's a small study planning to include 30 participants, and the current recruitment status is unclear. You could be eligible if you are over 18, need regular blood transfusions, and are willing to follow study procedures.

Study design

This is a small pilot study (single arm) with 30 participants to see if a home blood transfusion program is practical and acceptable.

What's involved

You would receive 1-2 blood products at home each week for a total of 5 weeks, along with home blood draws. You will also complete surveys and interviews.

Compensation

Not stated in the trial record.

Follow-up

The study measures feasibility and acceptability at 5 weeks, which is the duration of the home transfusion intervention.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.